Vidavo S.A.

ATH-VIDAVO
Athens Stock Exchange
Computer Programming, Data Processing, And Other Computer Related Services
Global Rank
#41132
Country Rank
#146
Market Cap
12.68 M
Price
12.06
Change (%)
0.95%
Volume
0

Vidavo S.A.'s latest marketcap:

12.68 M

As of 08/31/2026, Vidavo S.A.'s market capitalization has reached $12.68 M. According to our data, Vidavo S.A. is the 41132th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 12.68 M
Revenue (ttm) 4.75 M
Net Income (ttm) 1.52 M
Shares Out 1.04 M
EPS (ttm) 1.34
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 09/25/2026
Market Cap Chart
Data Updated: 08/31/2026

Vidavo S.A.'s yearly market capitalization.

Vidavo S.A. has seen its market value grow from €3.39 M to €10.94 M since 2014, representing a total increase of 223.13% and an annual compound growth rate (CAGR) of 10.58%.
Date Market Cap(€) Market Cap(USD) Change (%) Global Rank
08/31/2026 €10.94 M $12.68 M 57.25% 41132
12/31/2025 €5.66 M $6.57 M 134.04% 41615
12/31/2024 €2.42 M $2.5 M 17.62% 42774
12/29/2023 €2.06 M $2.27 M -21.07% 41507
12/30/2022 €2.6 M $2.79 M -32.49% 39652
12/31/2021 €3.86 M $4.38 M 28.56% 37650
12/31/2020 €3 M $0 -11.62% 34496
12/31/2019 €3.39 M $3.81 M 0% 31289
12/31/2018 €3.39 M $3.89 M 0% 30216
12/29/2017 €3.39 M $4.07 M 0.25% 29476

Company Profile

About Vidavo S.A.

Vidavo S.A. is a technology company specializing in connected health, wellness, and healthy ageing solutions. Founded in 2002 and headquartered in Thessaloniki, Greece, the company focuses on innovative digital health platforms.

Core Solutions

Vidavo's flagship product, Vida24, is a cloud-based platform with a customizable app that integrates multi-source data. The platform offers a comprehensive suite of health and wellness services, including:

  • Chronic disease management
  • Doctor on demand services
  • Nutrition and wellness programs
  • Marine telemedicine solutions
  • Behavioral change support
  • Insuretech and corporate wellbeing
  • Wearable device integration
  • Scientific wellness and digital therapeutics
  • Mental health assessments

Vidavo's modular approach allows for tailored e-health and m-health solutions to meet diverse healthcare needs.

Frequently Asked Questions

  • What is Vidavo S.A.'s (ATH-VIDAVO) current market cap?
    As of 08/31/2026, Vidavo S.A. (including the parent company, if applicable) has an estimated market capitalization of $12.68 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Vidavo S.A. global market capitalization ranking is approximately 41132 as of 08/31/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2026. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.